# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-050723
Filing Date
2021-09-30
Accepted
2021-09-30 11:42:01
Documents
23
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea148184-6k_immuron.htm | 6-K | 14554
2 | ANNUAL REPORT TO SHAREHOLDERS | ea148184ex99-1_immuron.htm | EX-99.1 | 1432300
3 | CORPORATE GOVERNANCE STATEMENT | ea148184ex99-2_immuron.htm | EX-99.2 | 80981
4 | APPENDIX 4G | ea148184ex99-3_immuron.htm | EX-99.3 | 112261
5 | GRAPHIC | image_001.jpg | GRAPHIC | 1395
6 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 155229
7 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 169039
8 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 2292
9 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 180732
10 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 169931
11 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 2896
12 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 2212
13 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 1809
14 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 185786
15 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 172202
16 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 3440
17 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 191435
18 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 2896
19 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 2538
20 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 1836
21 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 178850
22 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 161756
23 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 3698
| Complete submission text file | 0001213900-21-050723.txt |  | 3833724

Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 211294280
SIC: 2834 Pharmaceutical Preparations